Radiation-associated cutaneous mastocytosis: a case report and review of the literature

El Hussein S, Chifotides HT, Khoury JD, Verstovsek S, Thakral B. Systemic mastocytosis and other entities involving mast cells: a practical review and update. Cancers (Basel). 2022;14(14):3474.

https://doi.org/10.3390/cancers14143474

Di Raimondo C, Del Duca E, Silvaggio D, Di Prete M, Lombardo P, Mazzeo M, et al. Cutaneous mastocytosis: a dermatological perspective. Australas J Dermatol. 2021 Feb;62(1):e1–7.

https://doi.org/10.1111/ajd.13443

Chatterjee A, Ghosh J, Kapur R. Mastocytosis: a mutated kit receptor induced myeloproliferative disorder. Oncotarget. 2015;6(21):18250–64.

https://doi.org/10.18632/oncotarget.4213

Macdonald A, Feiwel M. Cutaneous mastocytosis: an unusual radiation dermatitis. Proc R Soc Med. 1971;64(1):29–30.

https://doi.org/10.1177/003591577106400118

Comte C, Bessis D, Dereure O, Guillot B. Urticaria pigmentosa localized on radiation field. Eur J Dermatol. 2003;13(4):408–9.

Soilleux EJ, Brown VL, Bowling J. Cutaneous mastocytosis localized to a radiotherapy field. Clin Exp Dermatol. 2009;34(1):111–2.

https://doi.org/10.1111/j.1365-2230.2008.02931.x

Davidson SJ, Coates D. Cutaneous mastocytosis extending beyond a radiotherapy site: a form of radiodermatitis or a neoplastic phenomenon? Australas J Dermatol. 2013;54(4):e85–7.

https://doi.org/10.1111/j.1440-0960.2012.00961.x

Hellen R, Kiely C, Murad A, Mulligan N, Coffey J, Lenane P, et al. Two cases of dermatoses koebnerizing within fields of previous radiotherapy. Clin Exp Dermatol. 2014;39(8):900–3.

https://doi.org/10.1111/ced.12421

Dalmasso C, Tournier É, de Lafontan B, Modesto A, Dalenc F, Chantalat É, et al. Uncommon dermatologic disorders triggered by radiation therapy of breast cancer: a case-series. Cancer Radiother. 2017;21(3):216–21.

https://doi.org/10.1016/j.canrad.2016.11.004

Tate C, Tang F, Lane SW, Seymour L. Clinical and molecular categorization of progressive, adult-onset cutaneous mastocytosis. JAAD Case Rep. 2017;4(1):30–2.

https://doi.org/10.1016/j.jdcr.2017.09.038

Easwaralingam N, Wu Y, Cheung D, Tiver K, Fuller S, Edirimanne S. Radiotherapy for breast cancer associated with a cutaneous presentation of systemic mastocytosis-a case report and literature review. J Surg Case Rep. 2018;2018(11):rjy317.

https://doi.org/10.1093/jscr/rjy317

Allen K, Marks K, Mathew B. Post-radiotherapy cutaneous mastocytosis. Diagn Histopathol. 2021;27(1):53–5.

https://doi.org/10.1016/j.mpdhp.2020.10.014

Murphy M, Valentini R, Shaughnessy E. Radiotherapy-associated cutaneous mastocytosis in a patient with breast carcinoma. Case report and review of the literature. Am J Dermatopathol. 2023;45(5):339–42.

https://doi.org/10.1097/DAD.0000000000002404

Pardanani A. Systemic mastocytosis in adults: 2023 update on diagnosis, risk stratification and management. Am J Hematol. 2023 Jul;98(7):1097–16.

https://doi.org/10.1002/ajh.26962

Albrecht M, Müller K, Köhn FM, Meineke V, Mayerhofer A. Ionizing radiation induces degranulation of human mast cells and release of tryptase. Int J Radiat Biol. 2007;83(8):535–41.

https://doi.org/10.1080/09553000701444657

Soule BP, Brown JM, Kushnir-Sukhov NM, Simone NL, Mitchell JB, Metcalfe DD. Effects of gamma radiation on FcεRI and TLR-mediated mast cell activation. J Immunol. 2007;179(5):3276–86.

https://doi.org/10.4049/jimmunol.179.5.3276

Wong TN, Ramsingh G, Young AL, Miller CA, Touma W, Welch JS, et al. Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia. Nature. 2015;518(7540):552–5.

https://doi.org/10.1038/nature13968